New research finds companies are identifying serious supply chain risks but few can show that they manage them

New research finds companies are identifying serious supply chain risks but few can show that they manage them Kumi Consulting’s... read more

17.09.2026 • By Kumi Consulting

Lifebit awarded 3-year NIHR BioResource TRE contract

London, UK — Sept 17, 2026 — Lifebit , a leading provider of secure biomedical data platforms and Trusted Research Environments (TREs), today... read more

17.09.2026 • By Lifebit

World Patient Safety Day: M.E Care is Failing WHO and NHS Safety Standards

UK social enterprise ME Foggy Dog is marking World Patient Safety Day 2026 by calling for urgent improvements to the safety and quality of care... read more

17.09.2026 • By ME Foggy Dog

AI Deadlock Signals the End of Volume-Based Cold Email, Says Maverrik

As sellers use AI to generate outreach and buyers use AI to filter it out, Maverrik says B2B sales is moving back towards high-value, low-volume... read more

16.09.2026 • By Maverrik

KNOW ALL MARKS THE 5TH WORLD ALL DAY ON SEPTEMBER 20, 2026!

On Sunday, September 20, 2026, we come together to mark World ALL Day, a global campaign aiming to raise awareness of acute lymphoblastic leukemia... read more

16.09.2026 • By Scientific Education Support

CN Respiratory Solutions Ltd announces UK patent grant for innovative respiratory treatment technology

For immediate release 15-9-2026— Cambridgeshire, UK CN Respiratory Solutions Ltd has been granted UK Patent GB2642565 for an innovative... read more

15.09.2026 • By CN Respiratory Solutions Ltd

Drinking More Than You Want To? New Book Explores What Really Helps People Drink Less or Stop

Glasgow author James McInally says problem drinking can remain remarkably well hidden behind careers, families and otherwise ordinary lives — and... read more

15.09.2026 • By James McInally

Can You Really Win Clients on LinkedIn? Maverrik Explains What Actually Works

Businesses are still winning new clients through LinkedIn, but according to social selling training company Maverrik, the companies seeing the... read more

09.09.2026 • By Maverrik

3.9 million Londoners experienced mental health challenges last year, but over a third have never accessed support

69% of Londoners experiencing mental health challenges say they disrupt everyday life 45% of those struggling cite money... read more

08.09.2026 • By Hestia

Building the world's evidence base to tackle drug-resistant tuberculosis

Oxford, UK, 8 September 2026: A new international programme, RESPECT-TB, coordinated by the Nuffield Department of Medicine at the University... read more

08.09.2026 • By Nuffield Department of Medicine, University of Oxford

1,000 WOMEN A DAY, 469 MPs, 17 OPPOSITION PARTIES – WILL THE PRIME MINISTER ACT ON WEDNESDAY?

Silent vigil opposite Downing Street to coincide with Andy Burnham’s second PMQs as campaigners ask him to turn unprecedented political support... read more

07.09.2026 • By Lobular Moon Shot Project

London Private GP Launches Next-Generation Longevity and Preventative Medicine Clinic to Combat Chronic Illness

London-based private GP clinic DrStavy.com has officially launched an advanced suite of longevity and preventative medicine services , designed... read more

19.08.2026 • By Dr Stavy

Geneyx Joins UK Government G-Cloud 15 Framework, Expanding UK Access to AI-Powered Genomic Analysis

New listing gives NHS organizations, public-sector genomic laboratories and research institutions a streamlined route to procure Geneyx's... read more

18.08.2026 • By Geneyx genomex Ltd

Five Signs Your Business Has Become Too Reliant on Referrals

Business growth expert says Referral Dependency is becoming one of the biggest hidden risks facing expert-led businesses across the UK. DEVON,... read more

06.08.2026 • By Maverrik

HOCHDORF Swiss Nutrition and Pharmalys Laboratories Announce Strategic Joint Venture to Accelerate Global Growth in Infant Nutrition, Backed by AS Equity Partners

Hochdorf, Switzerland – August 2, 2026  – HOCHDORF and Pharmalys are proud to announce the official launch of a new, jointly owned company,... read more

03.08.2026 • By AS Equity Partners

HOCHDORF Swiss Nutrition and Pharmalys Laboratories Announce Strategic Joint Venture to Accelerate Global Growth in Infant Nutrition, Backed by AS Equity Partners

Hochdorf, Switzerland – August 2, 2026  – HOCHDORF and Pharmalys are proud to announce the official launch of a new, jointly owned company,... read more

03.08.2026 • By AS Equity Partners

Three in Four Brits Don't Know What 'Cruelty-Free' Really Means, New Poll Reveals

Naturewatch Foundation says shoppers deserve clearer cruelty-free labelling A new YouGov poll commissioned by Naturewatch Foundation has... read more

03.08.2026 • By Naturewatch Foundation

Know Lung Cancer marks World Lung Cancer Day on August 1, 2026, with our “Together through Lung Cancer” campaign

Know Lung Cancer will mark World Lung Cancer Day on Saturday, August 1, 2026, uniting patients, caregivers, ambassadors, societies, and the wider... read more

29.07.2026 • By Scientific Education Support

UK charity hits the road to collect tonnes of prosthetic legs for African amputees

FOR IMMEDIATE RELEASE UK charity STAND has announced its “Legs on Tour 2026” appeal, an ambitious country-wide tour to collect tonnes of... read more

28.07.2026 • By STAND

Middle-aged women could lose nearly 6% of their muscle mass, according to new research

New data published in the Journal of Cachexia, Sarcopenia and Muscle, claims that women lose 5.7% of their lean muscle mass after the menopause,... read more

23.07.2026 • By Free Soul

Are British men embracing Botox Breaks? Definitely!

London, 23 July 2026 – Beauty tourism is getting a male makeover. New research from travel search engine KAYAK reveals that younger British men... read more

23.07.2026 • By KAYAK

What Is Referral Dependency? The Hidden Risk Facing Thousands of Growing Businesses

Plymouth, UK – 16th July 2026 – For many business owners, referrals are considered the gold standard of business development. They arrive with... read more

16.07.2026 • By Maverrik

Grünenthal strengthens its Genetic Medicine Capabilities and joins the Cluster for Nucleic Acid Therapeutics Munich

Aachen, Germany, 16 July 2026 – Grünenthal announced today that the company has joined the Cluster for Nucleic Acid Therapeutics Munich (CNATM),... read more

16.07.2026 • By news aktuell

AMRADNET UK now in the UK!

The UK does not need another teleradiology vendor. It needs diagnostic capacity partners who can help NHS Trusts and hospitals move patients from... read more

14.07.2026 • By AMRADNET UK

Quadruple amputee's 3,000-mile banger rally for Scotland's amputees

Cor Hutton has two prosthetic legs, two transplanted hands, one third of a lung and a recent kidney transplant. This August she's driving a... read more

13.07.2026 • By Finding Your Feet

Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy

Aachen, 08 July 2026 – Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric... read more

08.07.2026 • By news aktuell

CannabisRezept.berlin stellt BGVS™ vor: Struktur für Gutschein- und Anbieterfragen

Berlin, Juli 2026 – CannabisRezept.berlin erweitert seinen Orientierungsansatz für medizinisches Cannabis. Nach BCPS® – dem Berliner Cannabis... read more

06.07.2026 • By CannabisRezept Berlin

British Wheel of Yoga Announces Free Ayurveda for Sleep Masterclass

The British Wheel of Yoga (BWY) is inviting everyone to a completely free online masterclass, Ayurveda for Sleep , led by Ayurvedic expert and... read more

02.07.2026 • By British Wheel of Yoga

Maverrik Launches Build Beyond Referrals One-Day Intensive to Help Expert-Led Businesses Reduce Referral Dependency

New one-day intensive gives executive coaches, consultants and expert-led businesses a practical client acquisition system designed to reduce... read more

01.07.2026 • By Maverrik

Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist

The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy... read more

29.06.2026 • By news aktuell

Subscribe to our daily news alert to receive the latest Medical & Pharmaceutical press releases and news.